They are using subtle "Hints" to plant fear on investors minds. I am concern that we may have a "Wolf" operating under a "Sheep" skin.
This wolf is not able to present verifiable facts to substantiate why investors ought to reframe from buying and holding Gale shares. He is using psychological suggestions with the aim of confusing and scaring investors to stay away from buying and holding Gale.
Watching all bashers' messages on Gale over the last 30 months, this poisonous tactics have been use before. Fortunately, most long investors have conducted their won DD and these Septic Tank Maggots did not succeed. So, they will not succeed this time or any time in the future.
A couple of bashers are trying to spread lies to pour some dirty on my statements about how to deal with bashers.
Therefore this message deserves to be read by more investors!
As of Nov 25th, some 64 investors have indicated to me that they are true "LONGS" on Gale.
As of today (Nov 28th), the number of "LONGS" on my list has grown to 74. Here are their IDs:
peterharmisan fyreball27 zdoggeorge bushcosttinks drpaul202018 ptrderosa
pencil602 mekadik007 pasdedeuxmom readnews311
I sincerely thank those 74 LONGS who has joined this list. One of my original objective in developing this list is to form an effective force to handle those vicious bashers.
You should have read my recent message on "Basher Tactics from the Bashers Handbook". Therefore, we do have some effective ways to defeat them.
As to how Gale investors can effectively reduce the chances of the shorts, hedge funds and stock manipulators to steal our hard earn money is to do the following:
(1) Use a cash account to buy and hold Gale stocks.
(2) Ash your trading firm to lock your Gale shares, making sure that the written contract contains the correct legal wording.
(3) Set you sell price at very high levels such as $50 per share.
At the height of the bashing and manipulating some 6 to 9 months ago, some of us have been fighting against more than 350 bashers on this board. Eventually, they disappeared or some may be using new IDs up to this day.
I am fully confident that if we band together and use effective fighting tactics, "we shall overcome them"!
The fact that those directors have converted their options into shares and own them is good enough for me. They are still making the decision to have those share on hand indicating that they foresee that Gale's share price will rise much further in the near future.
Thanks Dan for alerting this for us. It is definitely a very positive "Omen" that higher prices will arrive soon.
Since there are 18 thumbs up on my message, I think I should put this on top some that many serious investors can read it.
Just Google "Bashers Handbook" and you should find answers to your questions.
I believe that they are paid by shorts, MMs, hedge fund managers and stock manipulators.
Some bashers are based in N. America, some in India or Pakistan and some may even be in Europe.
Not responding to their messages directly. Thumb them down and put them on Ignore is the best way to deal with all of them.
1: Remember, BASHERS NEVER BASH A BAD STOCK.
2: BASHERS ALWAYS BRING UP OLD NEWS THAT YOU HAVE HEARD MANY TIMES.
3: BASHERS POST MANY TIMES A DAY.
4: BASHERS WILL LIE TO YOUR FACE.
5: BASHERS KNOW YOU CAN'T VERIFY THEIR STATEMENTS.
6: BASHERS PLAY ON YOUR LACK OF KNOWLEDGE.
7: BASHERS PLAY ON YOUR LACK OF PATIENCE.
8: BASHERS BRING THE PRICE DOWN. That is the basher's job. The truth is not important. Lies are the norm. Post continuously on the board every day. They are trying to hit the newbies visiting the board. They are trying to wear out the longs on the board. They do whatever it takes to wear the longs out.
How to deal with Bashers?
IGNORE THEM FOLKS...how bashers are paid:
When you REPLY to bashers you give them an opportunity to earn 5-7 bucks. A basher will attempt to milk three to five replies per post at one to two dollars each. This way the basher spreads negative influence to as many stockholders as possible. A basher will create this discussion thread because it takes less time reading more messages than is necessary. This ultimately allows the basher more time to post and make money.
NEVER ENGAGE A BASHER; if you do so then YOU BECOME THE BASHER,S AID! Read the news, do your own homework and make your own decisions.
Gale has over $50 million cash and it will be burning around $7 million on each quarter.
Abstral will be generating around $4 million each quarter conservatively.
For those who keep LYING about dilution need to have their brains check out by a psychiatrist.
Present some fact to back up your empty claims.
We have many well informed Gale investors on this board who will not be fooled or scared by your delusional and empty proclamations!!!
Abstral will generate sufficient revenue and cash to Gale to finance any future cash needs.
Dilution is a thing of the past!
We used to have a good number of investors on this board posting factual information on Gale/NeuVax/FBP and Abstral.
Recently, we have many speculators, bashers and manipulators posting garbage.
Enough is enough! I think is should be very healthy to bring good facts on the table.
A great interpretation of what NeuVax may go through via the FDA Phase 3 clinical trial route!
Beyond $10? As far as I am concern, should be beyond $20+.
he always give valuable insights based on verifiable facts with logical and balanced views.
Needless to say, investors have not properly factor the success of NeuVax (good positive Phase 3 data and market potential) onto the current Gale share price.
Based on Brian's data, if NeuVax obtains FDA approval, the market should be around $4B+ which should yield a share price of $40+ per share. If we add the valuation of NeuVax+Herceptin combo, Gale share price ought to be $7B+ translating Gale's share price to around $70+ per share. This is of course an optimistic estimate.
I have not factor the success of Abstral and FBP into my projections.
We have seen many biotechs whose developmental drug did not reach FDA approval and their share prices dropped by 60%+ within days of their failures. Based on all known clinical trial results, NeuVax has a slight chance of not receiving FDA approval.
There is always an element of chance in life. Let us see if NeuVax can prove itself worth our while to wait.